Dana M Brantley-Sieders Selected Research

Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)

7/2015

Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dana M Brantley-Sieders Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 04/2004
11	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2005
9	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2008
5	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2009
4	Carcinogenesis 01/2016 - 11/2005
3	Vascular Remodeling 11/2005 - 01/2004
2	Melanoma (Melanoma, Malignant) 01/2009 - 11/2005
2	Adenocarcinoma 01/2008 - 11/2005
1	Hypoxia (Hypoxemia) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Triple Negative Breast Neoplasms 01/2018
1	Carcinoma (Carcinomatosis) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Inflammation (Inflammations) 01/2009
1	Colonic Neoplasms (Colon Cancer) 11/2005

Drug/Important Bio-Agent (IBA)

9	Phosphotransferases (Kinase)IBA 01/2018 - 01/2004
9	LigandsIBA 12/2017 - 01/2004
8	tyrosine receptor (receptor, tyrosine)IBA 01/2016 - 01/2004
7	EphA2 ReceptorIBA 01/2021 - 11/2005
5	Ephrin-A1 (Ephrin A1)IBA 01/2020 - 11/2005
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017 - 01/2008
4	EphrinsIBA 02/2012 - 01/2004
3	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2016
3	GlutaminaseIBA 01/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 04/2004
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2018
2	GTP Phosphohydrolases (GTPases)IBA 01/2008 - 11/2005
2	Eph Family Receptors (Eph Receptors)IBA 01/2008 - 04/2004
2	EphA1 Receptor (Eph Receptor)IBA 01/2008 - 01/2008
1	LeptinIBA 01/2022
1	Essential Amino AcidsIBA 01/2022
1	AntibodiesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Thromboxane Receptors (Thromboxane Receptor)IBA 12/2020
1	cadherin 5IBA 12/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Everolimus FDA Link 01/2020
1	Messenger RNA (mRNA)IBA 01/2018
1	EnzymesIBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018
1	PlasticsIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	matrigelIBA 01/2016
1	LipidsIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 07/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2015
1	Interleukin-4 (Interleukin 4)IBA 11/2014
1	CytokinesIBA 11/2014
1	Interleukin-13IBA 11/2014
1	Interleukin-10 (Interleukin 10)IBA 11/2014
1	c-Mer Tyrosine KinaseIBA 11/2014
1	ALW-II-41-27IBA 05/2014
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2012
1	EphA3 ReceptorIBA 08/2012
1	Bromodeoxyuridine (BrdU)IBA 08/2012
1	Epidermal Growth Factor (EGF)IBA 01/2010
1	Trastuzumab (Herceptin)FDA Link 01/2010
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Tyrosine (L-Tyrosine)FDA Link 06/2008
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2008
1	Small Interfering RNA (siRNA)IBA 11/2006
1	Conditioned Culture MediaIBA 11/2006

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2008
1	Drug Therapy (Chemotherapy) 01/2022